Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kohei Ninomiya
Institution:
Fujita Health University
Observed institution:
Fujita Health University
ORCID:
0000-0001-6232-0008
Observed ORCID:
0000-0001-6232-0008
OpenAlex ID:
A5059531186
Works
13
Awards
1
Cross-Disorder Analysis of Genic and Regulatory Copy Number Variations in Bipolar Disorder, Schizophrenia, and Autism Spectrum Disorder
2022
·
Itaru Kushima
, Masahiro Nakatochi
, et al.
·
Biological Psychiatry
·
69
PDF
Shared genetic components between metabolic syndrome and schizophrenia: Genetic correlation using multipopulation data sets
2022
·
Rei Aoki
, Takeo Saito
, et al.
·
Psychiatry and Clinical Neurosciences
·
27
PDF
Polygenic risk scores in schizophrenia with clinically significant copy number variants
2019
·
Satoru Taniguchi
, Kohei Ninomiya
, et al.
·
Psychiatry and Clinical Neurosciences
·
19
PDF
Suvorexant for insomnia in patients with psychiatric disorder: A 1‐week, open‐label study
2019
·
Taro Kishi
, Kenji Sakuma
, et al.
·
Neuropsychopharmacology Reports
·
17
PDF
Cost effectiveness of pharmacogenetic-guided clozapine administration based on risk of HLA variants in Japan and the UK
2021
·
Kohei Ninomiya
, Takeo Saito
, et al.
·
Translational Psychiatry
·
13
PDF
Copy number variations in RNF216 and postsynaptic membrane–associated genes are associated with bipolar disorder: a case‐control study in the Japanese population
2024
·
Masahiro Nakatochi
, Itaru Kushima
, et al.
·
Psychiatry and Clinical Neurosciences
·
7
PDF
Effect of a brief cognitive behavioral program on depressive symptoms among newly licensed registered nurses: An observational study
2020
·
Kosei Esaki
, Masashi Ikeda
, et al.
·
PLoS ONE
·
7
Pharmacogenomic-guided clozapine administration based on HLA-DQB1, HLA-B and SLCO1B3-SLCO1B7 variants: an effectiveness and cost-effectiveness analysis
2022
·
Kohei Ninomiya
, Takeo Saito
, et al.
·
Frontiers in Pharmacology
·
6
Association of plasma arachidonic acid levels with a bipolar disorder and the effects of a FADS gene variant
2024
·
Takuma Ashizawa
, Takeo Saito
, et al.
·
Translational Psychiatry
·
4
PDF
Cost‐effectiveness analysis of pharmacogenetic‐guided antiseizure medication therapy based on the risk of HLA‐A*31:01 allele variants in Japan
2025
·
Yasushi Maruyama
, Hiroki Kimura
, et al.
·
Psychiatry and Clinical Neurosciences Reports
·
1
PDF
A cross‐national cost‐effectiveness analysis of brivaracetam focusing on psychiatric and behavioral adverse effects
2025
·
Yasushi Maruyama
, Hiroki Kimura
, et al.
·
Epilepsia Open
Cost-effectiveness of screening for HLA-B*59:01 prior to initiation of clozapine.
2019
·
Kohei Ninomiya
·
Asian College of Neuropsychopharmacology
M84 Polygenic Risk Scores in Schizophrenia With Clinically Significant Copy Number Variants
2019
·
Satoru Taniguchi
, Kohei Ninomiya
, et al.
·
European Neuropsychopharmacology
Show more works
View as search
Works count:
13
Citation count:
170
H-index:
7
I10-index:
5
Year
Topic
Type